G1 Therapeutics, Inc.
SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES

Last updated:

Abstract:

This invention is in the area of synthesizing pyrimidine-based compounds useful in the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.

Status:
Application
Type:

Utility

Filling date:

14 Dec 2020

Issue date:

29 Apr 2021